Sina Salati
1 
, Bahare Firouzbakht
2 , Padideh Daneii
3 , Ali Azarpey
4 , Behnaz Hatami
3 , Mohammad Mehdi Johari Moghadam
5 , Negar Jafari
6* 1 Department of Nursing, Kashmar School of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran
2 Department of Anesthesiology, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States
4 School of Medicine, Emory University, Atlanta, Georgia, United States
5 School of Medicine, University of California, Davis, Sacramento, California, United States
6 Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
Abstract
Cancer treatment can lead to combined heart and kidney complications, which can have a significant impact on patient outcomes. Chemotherapy and radiation therapy used to treat cancer can cause damage to both the heart and kidneys, leading to a range of complications. Managing combined heart and kidney complications following cancer treatment requires a collaborative and multidisciplinary approach, with regular monitoring and personalized management plans tailored to the individual patient’s needs.
Implication for health policy/practice/research/medical education:
Oncocardiology is an emerging field focusing on the intersection of heart and cancer diseases. It involves cooperating with cardiology, nephrology, and oncology teams to treat cardiorenal disease patients.
Please cite this paper as: Salati S, Firouzbakht B, Daneii P, Azarpey A, Hatami B, Johari Moghadam MM, Jafari N. Oncocardiology: close collaboration between oncologists, cardiologists, and nephrologists . J Nephropharmacol. 2024;13(1):e11660. DOI: 10.34172/ npj.2023.11660.